Budget impact and cost per responder analysis of upadacitinib for the treatment of moderate to severe atopic dermatitis from the perspective of the social security and the private sector in Argentina

Author:

Espinola Natalia1,Rodríguez Cairoli Federico1ORCID,Rojas-Roque Carlos12ORCID,Luna Paula Carolina3,Kanevsky Diego4,Migliazza Valeria5,Pichon-Riviere Andrés16

Affiliation:

1. Department of Health Technology Assessment and Health Economics, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina

2. Centre for Health Economics (CHE), Alcuin ‘A’ Block, University of York, York, UK

3. Dermatology Department, Hospital Alemán, Buenos Aires, Argentina

4. Market Access Department, AbbVie, Buenos Aires, Argentina

5. Medical Department, AbbVie, Buenos Aires, Argentina

6. Center for Research in Epidemiology and Public Health, National Scientific and Technical Research Council, Buenos Aires, Argentina

Funder

AbbVie

Publisher

Informa UK Limited

Reference24 articles.

1. Atopic dermatitis

2. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: A global synthesis

3. Epidemiology of atopic dermatitis in adults: Results from an international survey

4. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

5. [National Administration of Drugs Food and Medical Technology (ANMAT)]. National administration of drugs food and medical technology (ANMAT)] [internet]. Website of the ANMAT; 2017 [cited 2023 Feb 12]. Available from: https://www.argentina.gob.ar/anmat

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3